Home›Companies›Biotech & Pharma›Myra EB Bio

Myra EB Systems LLC

Develops an oral therapy for children with rare inherited diseases.

Updated Nov 10, 2026·Latest SEC filing Apr 7, 2026·Suggest an edit

About Myra EB Bio

Myra EB Bio is a private company based in Boxborough, Massachusetts. It has reported $10,000 raised in one offering on Form D since April 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 24, 2026Apr 7, 2026$10,000of $2.0M target1$10,000Debt, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Myra EB Bio's Form D filed Apr 7, 2026.

PK
Paul Kingma
Chief Medical Advisor
VS
Vijesh Sharma
Chief Operating Officer, Co-Founder and Director
HK
Hassan Khan
Chief Accounting Consultant and Director
NK
Navneet Kumar
Executive officer

Sources

  1. SECMyra EB Systems LLC filing history
  2. CompanyAbout Myra EB Bio